2014 New Orleans Summer Cancer Meeting

breast cancer

Tackling the Heterogeneity of Triple-Negative Breast Cancer

Triple-negative breast cancer is now recognized as a very complex subtype for which one treatment will not be applicable to all, according to Mohammad Jahanzeb, MD, Professor of Clinical Medicine at t...

Issues in Oncology

Quest for Targeted Therapeutic ‘Cocktails’ Hits Roadblocks

The use of cutting-edge technology and bioinformatics to inform clinical decision-making in oncology is still a ways off, according to Mark Pegram, MD, the Susy Yuan-Huey Hung Professor of Oncology an...

Advertisement

Advertisement



;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.